Anti-EGFR重组抗体|科研级 Nimotuzumab ( 尼妥组单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-EGFR重组抗体|科研级 Nimotuzumab ( 尼妥组单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-EGFR重组抗体|科研级 Nimotuzumab ( 尼妥组单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1033

Alias

科研级 Nimotuzumab ( 尼妥组单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Nimotuzumab

Molecular Name

Nimotuzumab

Size

￥500/100ug, ￥3200/1mg, ￥6800/5mg, 定制报价/10mg以上

CAS Number

828933-51-3

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Molecular Weight

148 kDa

Applications

ELISA, IP, FC, FuncS, Neut, IF, IHC

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

EGFR[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Nimotuzumab (h-R3, BIOMAb EGFR, Biocon, India, TheraCIM, CIMYM Biosciences, Canada, Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用，不得用于人体或治疗用途。

靶点背景信息

实验方案&FAQ